STRS Ohio’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

STRS Ohio’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-80	Closed	-$8K	–	2322
2020 Q3	$8K	Hold	80	–	–	﹤0.01%	2143
2020 Q2	$7K	Hold	80	–	–	﹤0.01%	2116
2020 Q1	$6K	Hold	80	–	–	﹤0.01%	1971
2019 Q4	$6K	Hold	80	–	–	﹤0.01%	2025
2019 Q3	$9K	Hold	80	–	–	﹤0.01%	2029
2019 Q2	$14K	Hold	80	–	–	﹤0.01%	2059
2019 Q1	$12K	Hold	80	–	–	﹤0.01%	2002
2018 Q4	$20K	Hold	80	–	–	﹤0.01%	1994
2018 Q3	$19K	Hold	80	–	–	﹤0.01%	2043
2018 Q2	$18K	Buy	+80	New	+$23.3K	﹤0.01%	2065

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

STRS Ohio's EVLO Position: Q4 2020 in Review

STRS Ohio sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2020, closing a stake of 80 shares — an estimated $8K sold.

STRS Ohio first reported a position in EVLO in Q2 2018 and held it in 10 quarters. The position peaked at $20K in Q4 2018. 49 funds tracked by Wall St. Rank hold EVLO as of Q4 2020.

STRS Ohio reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
STRS Ohio sold 80 Evelo Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $8K.
STRS Ohio first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
STRS Ohio's Evelo Biosciences, Inc. Common Stock position peaked at $20K in Q4 2018.
49 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.